[
  {
    "ts": null,
    "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of September 21",
    "summary": "This is our weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read the latest in the article series here.",
    "url": "https://finnhub.io/api/news?id=5f623d6b6171fb1275bbe4fef41c4cb5cf50ccda63dc6337f12605fc6855b5c4",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758306089,
      "headline": "Dividend Champion, Contender, And Challenger Highlights: Week Of September 21",
      "id": 136822784,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1072593728/image_1072593728.jpg?io=getty-c-w1536",
      "related": "MDT",
      "source": "SeekingAlpha",
      "summary": "This is our weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read the latest in the article series here.",
      "url": "https://finnhub.io/api/news?id=5f623d6b6171fb1275bbe4fef41c4cb5cf50ccda63dc6337f12605fc6855b5c4"
    }
  },
  {
    "ts": null,
    "headline": "Why Medtronic (MDT) Should Be Part of Your Dividend Stock Portfolio in 2025",
    "summary": "Medtronic plc (NYSE:MDT) is included among the Best Stocks for a Dividend Stock Portfolio. Medtronic plc (NYSE:MDT), one of the leading names in medical devices, has faced some challenges in recent years but has taken measures to address them, with a particular emphasis on strengthening profitability. In the past, the company considered spinning off certain divisions […]",
    "url": "https://finnhub.io/api/news?id=d2c98d574623935b49b27f593084bc1035cc3b5d5877546f150d931602eb5783",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758298237,
      "headline": "Why Medtronic (MDT) Should Be Part of Your Dividend Stock Portfolio in 2025",
      "id": 136820042,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Medtronic plc (NYSE:MDT) is included among the Best Stocks for a Dividend Stock Portfolio. Medtronic plc (NYSE:MDT), one of the leading names in medical devices, has faced some challenges in recent years but has taken measures to address them, with a particular emphasis on strengthening profitability. In the past, the company considered spinning off certain divisions […]",
      "url": "https://finnhub.io/api/news?id=d2c98d574623935b49b27f593084bc1035cc3b5d5877546f150d931602eb5783"
    }
  },
  {
    "ts": null,
    "headline": "Smart Medical Devices Market Size to Reach $180.4 Billion by 2033 - Strategic Growth Opportunities in Chronic Disease Management, Digital Health, and Connected Care",
    "summary": "The Smart Medical Devices Market Size valued at US$ 61.7 billion in 2024, is projected to reach US$ 180.4 billion by 2033, expanding at a CAGR of 12.8% (2025–2033), according to the latest report from DataM Intelligence.",
    "url": "https://finnhub.io/api/news?id=fc380aea7af01c62adf05acb278a840974c59d45571e83947b5269b2869071f6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758295800,
      "headline": "Smart Medical Devices Market Size to Reach $180.4 Billion by 2033 - Strategic Growth Opportunities in Chronic Disease Management, Digital Health, and Connected Care",
      "id": 136820021,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "The Smart Medical Devices Market Size valued at US$ 61.7 billion in 2024, is projected to reach US$ 180.4 billion by 2033, expanding at a CAGR of 12.8% (2025–2033), according to the latest report from DataM Intelligence.",
      "url": "https://finnhub.io/api/news?id=fc380aea7af01c62adf05acb278a840974c59d45571e83947b5269b2869071f6"
    }
  },
  {
    "ts": null,
    "headline": "Medtronic secures FDA approval for the Altaviva™ device, a simple experience for treating urge urinary incontinence",
    "summary": "Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announced today that it has received U.S. Food and Drug Administration (FDA) approval for the Altaviva™ device. The minimally invasive implantable tibial neuromodulation (ITNM) therapy is inserted near the ankle and designed to treat urge urinary incontinence.",
    "url": "https://finnhub.io/api/news?id=b7b4d87c38084c58bb690535e4bffc06972a3e0f20b86821f148d6901014e80e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758286800,
      "headline": "Medtronic secures FDA approval for the Altaviva™ device, a simple experience for treating urge urinary incontinence",
      "id": 136818445,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MDT",
      "source": "Yahoo",
      "summary": "Medtronic plc (NYSE: MDT), a global leader in healthcare technology, announced today that it has received U.S. Food and Drug Administration (FDA) approval for the Altaviva™ device. The minimally invasive implantable tibial neuromodulation (ITNM) therapy is inserted near the ankle and designed to treat urge urinary incontinence.",
      "url": "https://finnhub.io/api/news?id=b7b4d87c38084c58bb690535e4bffc06972a3e0f20b86821f148d6901014e80e"
    }
  }
]